Patrick Bilbo
CIK 1759203 · View on SEC EDGAR ↗
First SEC filing: April 5, 2021 · Latest: April 5, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2025 | ORGO | A | 190,475 | — | — | 190,475 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 19, 2025 | ORGO | A | 184,136 | — | — | 949,062 Direct | +24.07% | Acquired | (price as of 2026-08-19) |
| Feb. 16, 2025 | ORGO | F | 790 | $3.70 | $2,923 | 764,926 Direct | -0.10% | Disposed | -50.0% (price as of 2026-08-19) |
| Feb. 15, 2025 | ORGO | F | 3,883 | $3.70 | $14,367 | 765,716 Direct | -0.50% | Disposed | -50.0% (price as of 2026-08-19) |
| Feb. 15, 2025 | ORGO | F | 25,739 | $3.70 | $95,234 | 769,599 Direct | -3.24% | Disposed | -50.0% (price as of 2026-08-19) |
| Feb. 15, 2025 | ORGO | F | 13,744 | $3.70 | $50,853 | 795,338 Direct | -1.70% | Disposed | -50.0% (price as of 2026-08-19) |
| April 1, 2024 | ORGO | F | 2,497 | $2.80 | $6,992 | 809,082 Direct | -0.31% | Disposed | -33.9% (price as of 2026-08-19) |
| March 28, 2024 | ORGO | M | 152,250 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-19) |
| March 28, 2024 | ORGO | M | 152,250 | $1.18 | $179,655 | 811,579 Direct | +23.09% | Acquired | 56.8% (price as of 2026-08-19) |
| Feb. 21, 2024 | ORGO | A | 338,674 | — | — | 338,674 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 21, 2024 | ORGO | A | 187,318 | — | — | 659,329 Direct | +39.69% | Acquired | (price as of 2026-08-19) |
| Feb. 16, 2024 | ORGO | F | 791 | $3.48 | $2,753 | 472,011 Direct | -0.17% | Disposed | -46.8% (price as of 2026-08-19) |
| Feb. 15, 2024 | ORGO | F | 4,608 | $3.68 | $16,957 | 472,802 Direct | -0.97% | Disposed | -49.7% (price as of 2026-08-19) |
| Feb. 15, 2024 | ORGO | F | 24,925 | $3.68 | $91,724 | 477,410 Direct | -4.96% | Disposed | -49.7% (price as of 2026-08-19) |
| April 1, 2023 | ORGO | F | 2,678 | $2.13 | $5,704 | 502,335 Direct | -0.53% | Disposed | -13.1% (price as of 2026-08-19) |
| Feb. 22, 2023 | ORGO | A | 388,654 | — | — | 388,654 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 22, 2023 | ORGO | A | 327,386 | — | — | 505,013 Direct | +184.31% | Acquired | (price as of 2026-08-19) |
| Feb. 16, 2023 | ORGO | F | 936 | $2.75 | $2,574 | 177,627 Direct | -0.52% | Disposed | -32.7% (price as of 2026-08-19) |
| Feb. 15, 2023 | ORGO | F | 4,599 | $2.92 | $13,429 | 178,563 Direct | -2.51% | Disposed | -36.6% (price as of 2026-08-19) |
| April 1, 2022 | ORGO | F | 2,497 | $7.89 | $19,701 | 183,162 Direct | -1.34% | Disposed | -76.6% (price as of 2026-08-19) |
| Feb. 16, 2022 | ORGO | F | 937 | $7.78 | $7,290 | 185,659 Direct | -0.50% | Disposed | -76.2% (price as of 2026-08-19) |
| Feb. 15, 2022 | ORGO | A | 125,522 | — | — | 125,522 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 15, 2022 | ORGO | A | 52,926 | — | — | 186,596 Direct | +39.59% | Acquired | (price as of 2026-08-19) |
| April 1, 2021 | ORGO | F | 2,497 | $19.83 | $49,516 | 164,120 Direct | -1.50% | Disposed | -90.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 19, 2025 | ORGO | Stock Option (Right to Buy) | Class A Common Stock (190,475) | $3.53 | Feb. 19, 2035 | 190,475 | Acquired |
| March 28, 2024 | ORGO | Stock Option (Right to Buy) | Class A Common Stock (152,250) | $1.18 | April 10, 2024 | 152,250 | Disposed |
| Feb. 21, 2024 | ORGO | Stock Option (Right to Buy) | Class A Common Stock (338,674) | $3.43 | Feb. 21, 2034 | 338,674 | Acquired |
| Feb. 22, 2023 | ORGO | Stock Option (Right to Buy) | Class A Common Stock (388,654) | $2.51 | Feb. 22, 2033 | 388,654 | Acquired |
| Feb. 15, 2022 | ORGO | Stock Option (Right to Buy) | Class A Common Stock (125,522) | $8.03 | Feb. 15, 2032 | 125,522 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $514,478 | — | — | — | $441,377 | — | $62,091 | $2,116,928 |
| 2024 | $489,303 | — | — | — | $461,749 | — | $41,356 | $2,276,634 |
| 2023 | $472,944 | $277,944 | — | — | — | — | $55,606 | $2,156,855 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.